ABSTRACT
Background@#The aim of this study was to estimate the prevalence of the beta thalassemia trait (BTT) and differentiate it from iron-deficiency anemia (IDA) among blood donors. @*Methods@#A total of 1,000 samples from blood donors were subjected to complete hemogram with red blood cell indices. Further, Mentzer index (MI) was calculated for samples with mean corpuscular volume (MCV) below 80 fL and mean corpuscular hemoglobin (MCH) below 27 pg. Samples with Mentzer index ＜12 were subjected to naked-eye single-tube red cell osmotic fragility test (NESTROFT) followed by hemoglobin electrophoresis in positive cases. Serum ferritin was assessed in NESTROFT-negative cases. @*Results@#The prevalence of BTT among blood donors was 3.7% and that of microcytosis among donors was 8.6%. The prevalence of BTT among microcytic donors was 41.8% while that among those with IDA was 11.6%. A value of MI ＜13 was highly sensitive in the diagnosis of BTT. MI ＞13 was found to have both high specificity and high sensitivity for diagnosing IDA. @*Conclusion@#A moderately high prevalence of BTT was observed among blood donors. Presently, no screening program is mandatory for screening of BTT among blood donors. Indices like MCV, MCH, and Mentzer Index were thus found to be effective to screen for BTT and IDA among blood donors, and NESTROFT was a cost-effective mass screening method to differentiate BTT and IDA.
ABSTRACT
A 23-year-old male presented with pulmonary tuberculosis and swelling of both lower limbs. He was put on antitubercular treatment. Hemogram showed mild anemia and Pseudo Pelger-huet cells. The bone marrow (BM) examination showed 52% promyelocytes with regular round to oval nuclei, few granules and were positive for CD13 and CD33, and negative for HLA-DR. Cytogenetic analysis of the BM aspirate revealed an apparently balanced t(11;17)(q23;q21). Final diagnosis rendered was acute promyelocytic leukemia (APL) with t(11;17)(q23;q21); ZBTB16/RARA. APL is a distinct subtype of acute myeloid leukemia. The variant APL with t(11;17)(q23;q21) cases that are associated with the ZBTB16/RARA fusion gene have been reported as being resistant to all-trans-retinoic acid (ATRA). Therefore, differential diagnosis of variant APL with t(11;17)(q23;q12) from classical APL with t(15;17)(q22;q12); PML-RARA is very important. Here we have discussed the importance of distinct morphology of variant APL and also significance of rare presentation with tuberculosis.
Subject(s)
Humans , Male , Young Adult , Anemia , Bone Marrow , Cytogenetic Analysis , Diagnosis, Differential , Granulocyte Precursor Cells , HLA-DR Antigens , Leukemia, Myeloid, Acute , Leukemia, Promyelocytic, Acute , Lower Extremity , Tretinoin , Tuberculosis , Tuberculosis, PulmonaryABSTRACT
Primary splenic lymphoma is a rare disease. It can be defined as a lymphomatous process involving the spleen alone or the spleen and splenic lymph nodes. These lymphomas are usually of non-Hodgkin's type, originating from B-cells. The criteria used for primary splenic lymphoma includes primary symptoms due to splenomegaly, no lymphadenopathy or liver involvement and an interval of 6 months or longer between the detection of splenic involvement and appearance of lymphoma elsewhere. We report a case of a 37-year old female patient who presented with loss of weight and heaviness on the left side of abdomen for duration of 6 months. Splenectomy was performed which revealed non-Hodgkin's lymphoma, B-cell type localized to spleen and splenic hilar lymph nodes